EUR 32.66
(2.7%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 61.59 Million SEK | 85.65% |
2022 | 33.17 Million SEK | -0.41% |
2021 | 33.31 Million SEK | -28.04% |
2020 | 46.29 Million SEK | 147.79% |
2019 | 18.68 Million SEK | -41.94% |
2018 | 32.17 Million EUR | -46.98% |
2017 | 60.69 Million EUR | 208.0% |
2016 | 19.7 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 778.65 Million SEK | 3.46% |
2024 Q1 | 63.44 Million SEK | 5.86% |
2024 Q2 | 752.61 Million EUR | 3.22% |
2023 Q3 | 54.43 Million SEK | 71.0% |
2023 Q4 | 61.59 Million SEK | 13.15% |
2023 FY | 61.59 Million SEK | 85.65% |
2023 Q2 | 31.83 Million SEK | -4.44% |
2023 Q1 | 33.31 Million SEK | 0.4% |
2022 Q4 | 33.17 Million SEK | -1.95% |
2022 Q1 | 31.86 Million EUR | -4.35% |
2022 Q2 | 29.46 Million EUR | -7.52% |
2022 Q3 | 33.83 Million EUR | 14.83% |
2021 Q4 | 33.31 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 1.23 Billion EUR | 95.0% |
Carl Zeiss Meditec AG | 3.03 Billion EUR | 97.969% |
Fielmann Aktiengesellschaft | 2.13 Billion EUR | 97.116% |
Gerresheimer AG | 3.42 Billion EUR | 98.204% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 99.369% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 99.369% |